| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dimethyl Fumarate | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Fluticasone | FAERS: 3 | US FAERS | |
| 3 | Sunitinib | FAERS: 3 | US FAERS | |
| 4 | apixaban | FAERS: 3 | US FAERS | |
| 5 | Afatinib | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Cabozantinib S-malate | FAERS: 2 | US FAERS | |
| 7 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 8 | MDV 3100 | FAERS: 2 | US FAERS | |
| 9 | Tadenan | FAERS: 2 | US FAERS | |
| 10 | chlorhexidine gluconate | FAERS: 2 | US FAERS | |
| 11 | pirfenidone | FAERS: 2 | US FAERS | |
| 12 | Albuterol | FAERS: 1 | US FAERS | |
| 13 | Anoro Ellipta | FAERS: 1 | US FAERS | |
| 14 | Atovaquone | FAERS: 1 | US FAERS | |
| 15 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 16 | Colchicine | FAERS: 1 | US FAERS | |
| 17 | Cyclosporine | FAERS: 1 | US FAERS | |
| 18 | Dextromethorphan | FAERS: 1 | US FAERS | |
| 19 | Doxycycline | FAERS: 1 | US FAERS | |
| 20 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 21 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 22 | Everolimus | FAERS: 1 | US FAERS | |
| 23 | Ezetimibe | FAERS: 1 | US FAERS | |
| 24 | Famotidine | FAERS: 1 | US FAERS | |
| 25 | Gefitinib | FAERS: 1 | US FAERS | |
| 26 | Iohexol | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Lansoprazole | FAERS: 1 | US FAERS | |
| 28 | Linezolid | FAERS: 1 | US FAERS | |
| 29 | Lisdexamfetamine Dimesylate | FAERS: 1 | US FAERS | |
| 30 | N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide | FAERS: 1 | US FAERS | |
| 31 | Nebivolol | FAERS: 1 | US FAERS | |
| 32 | Norgestrel | FAERS: 1 | US FAERS | |
| 33 | Oseltamivir | FAERS: 1 | US FAERS | |
| 34 | PCI 32765 | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Pregabalin | FAERS: 1 | US FAERS | |
| 36 | Selegiline | FAERS: 1 | US FAERS | |
| 37 | Sorafenib | FAERS: 1 | US FAERS | |
| 38 | Teriparatide | FAERS: 1 | US FAERS | |
| 39 | Thyroxine | FAERS: 1 | US FAERS | |
| 40 | Ticagrelor | FAERS: 1 | US FAERS | |
| 41 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 42 | Warfarin | FAERS: 1 | US FAERS | |
| 43 | alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination | FAERS: 1 | US FAERS | |
| 44 | lenvatinib | FAERS: 1 | US FAERS | |
| 45 | regadenoson | FAERS: 1 | US FAERS | |
| 46 | tiotropium-olodaterol | FAERS: 1 | US FAERS | |
| 47 | tofacitinib | FAERS: 1 | US FAERS | |
| 48 | treprostinil | FAERS: 1 | US FAERS | |
| 49 | Ascorbic Acid | Canada Vigilance: 1 | Canada Vigilance | |
| 50 | Clarithromycin | Canada Vigilance: 1 | Canada Vigilance | |
| 51 | Mirtazapine | Canada Vigilance: 1 | Canada Vigilance | |
| 52 | Rabeprazole | Canada Vigilance: 1 | Canada Vigilance | |
| 53 | Varenicline | Canada Vigilance: 1 | Canada Vigilance | |
| 54 | cabazitaxel | Canada Vigilance: 1 | Canada Vigilance | |
| 55 | cefprozil | Canada Vigilance: 2 | Canada Vigilance | |
| 56 | pazopanib | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.